Table 3 Clinical features, angiographic characteristics, and treatment of young patients after a coronary event with or without FH
Variable | Total | FH statusa | |||
|---|---|---|---|---|---|
Probable/Definite (> 5 points) | Possible (3–5 points) | None (< 3 points) | P | ||
Diagnosis | |||||
STEMI, n(%) | 468 (54.1) | 16 (43.2) | 126 (48.6) | 326 (57.3) | 0.027 |
NONSTEMI, n(%) | 75 (8.7) | 0 (0.0) | 29 (11.2) | 46 (8.1) | 0.054 |
UAP, n(%) | 314 (36.3) | 21 (56.8) | 101 (39.0) | 192 (33.7) | 0.010 |
SAP, n(%) | 8 (0.9) | 0 (0.0) | 3 (1.2) | 5 (0.9) | 0.774 |
Coronary angiography | |||||
None, n(%) | 100 (11.6) | 1 (2.7) | 33 (12.7) | 66 (11.6) | 0.216 |
Single vessel, n(%) | 448 (51.8) | 8 (21.6) | 131 (50.6) | 309 (54.3) | 0.001 |
Double vessel, n(%) | 195 (22.5) | 13 (35.1) | 57 (22.3) | 125 (21.9) | 0.173 |
Triple vessel, n(%) | 110 (12.7) | 13 (35.1) | 34 (13.1) | 63 (11.1) | 0.000 |
Left main, n(%) | 61 (7.1) | 3 (8.1) | 13 (5.0) | 45 (7.9) | 0.312 |
CTO, n(%) | 270 (31.2) | 17 (45.9) | 83 (32.2) | 170 (29.9) | 0.115 |
Multivessel lesion, n (%) | 317 (36.6) | 28 (75.7) | 95 (36.7) | 194 (34.1) | 0.000 |
Gensini | 32 (10–64) | 50 (14–82) | 32 (10–64) | 32 (9–56) | 0.008 |
Operation | |||||
PCI, n(%) | 539 (62.3) | 20 (54.1) | 176 (68.0) | 343 (60.3) | 0.061 |
CABG, n(%) | 90 (10.4) | 12 (32.4) | 17 (6.6) | 61 (10.7) | 0.000 |
PTCA, n(%) | 20 (2.3) | 0 (0.0) | 6 (2.3) | 14 (2.5) | 0.628 |
Medication at discharge | |||||
Aspirin, n(%) | 819 (94.7) | 36 (97.3) | 251 (96.9) | 532 (93.5) | 0.098 |
β-blocker, n(%) | 701 (81.0) | 26 (70.3) | 216 (83.4) | 459 (80.7) | 0.151 |
ACEI/ARB, n(%) | 472 (54.6) | 13 (35.1) | 146 (56.4) | 313 (55.0) | 0.049 |
Statins, n(%) | 719 (83.1) | 28 (75.7) | 226 (87.3) | 465 (81.7) | 0.067 |
High-dose statins, n(%) | 67 (7.7) | 2 (5.4) | 21 (8.1) | 44 (7.7) | 0.847 |
Ezetimibe, n(%) | 40 (4.6) | 9 (24.3) | 15 (5.8) | 16 (2.8) | 0.000 |